What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Why Facility Upgrades Matter in 503B Outsourcing

Why Facility Upgrades Matter in 503B Outsourcing

In 503B outsourced compounding, facilities directly impact quality, safety, and scalability.

ProRx Pharma recently expanded its operations with new ISO-certified clean rooms, automation, and robotic technologies designed to strengthen compliance, efficiency, and production capacity. These upgrades support growing demand for compounded preparations used in preventative-, functional-, and longevity-focused therapies across telehealth, concierge medicine, med spas, and clinic-based care. Read More >

ProRx Pharma

ProRx Pharma News & Announcements

ProRx Pharma is an FDA-registered 503B facility focused on providing essential compounded sterile and non-sterile preparations. The company compounds products and formulations for medical institutions, physician offices, and 503A pharmacies, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Why Facility Upgrades Matter in 503B Outsourcing

Name
Address
Subscribe